Dow Down 1.17% Nasdaq Down 1.19%

ArQule Inc. (ARQL)

-NasdaqGM
1.65 0.00(0.00%) 4:00PM EDT
Prev Close:1.65
Open:1.67
Bid:1.65 x 1200
Ask:3.50 x 300
1y Target Est:3.92
Beta:1.44632
Next Earnings Date: 4-May-16ARQL Earnings announcement
Day's Range:1.62 - 1.73
52wk Range:1.37 - 2.65
Volume:113,113
Avg Vol (3m):131,713
Market Cap:117.25M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARQL

Comparison

Symbol% ChgMkt Cap
ARQL 0.00%117.25M
ARRYDown 1.83%460.11M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.36
Quarterly EPS Est (Mar-16) :-0.07
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-1.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met recepto... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback